A new approach to grading and treating COPD based on clinical phenotypes: Summary of the Spanish COPD guidelines (GesEPOC)

Primary Care Respiratory Journal

Volumn 22, Issue 1, 2013, Pages 117-121

  Miravitlles, Marc ^a,b   Soler Cataluña, Juan José ^c   Calle, Myriam ^d   Molina, Jesús ^e   Almagro, Pere ^f   Quintano, José Antonio ^g   Trigueros, Juan Antonio ^h   Piñera, Pascual ⁱ   Simón, Adolfo ^j   Riesco, Juan Antonio ^b,k   Ancochea, Julio ^l   Soriano, Joan B ^b,m  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e Centro de Salud Francia   (Spain)

^f HOSPITAL MÚTUA DE TERRASSA   (Spain)

^g Centro de Salud Lucena I   (Spain)

^h Centro de Salud Menasalbas   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^j HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^k HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^l Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas   (Spain)

^m Program of Epidemiology and Clinical Research CIMERA   (Spain)

more..

Author keywords

COPD; Guidelines; Treatment

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CARBOCISTEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MUCOLYTIC AGENT; PHOSPHODIESTERASE IV INHIBITOR; ROFLUMILAST; SHORT ACTING DRUG; THEOPHYLLINE;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EMPHYSEMA; FORCED EXPIRATORY VOLUME; HUMAN; MEDICAL SOCIETY; NATIONAL HEALTH SERVICE; PHENOTYPE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PROGNOSIS; SPAIN;

DECISION TREES; HUMANS; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 84874682687     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2013.00016     Document Type: Article

References (31)

1. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010. London: National Clinical Guideline Centre. Available from: http://guidance.nice.org.uk/CG101/Guidance/pdf/English
2. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2007 update. Can Respir J 2007;14(Suppl B):5-32B.
3. Nagai A, Aizawa H, Aoshiba K, et al. Guidelines for the diagnosis and treatment of COPD. 3rd ed. Tokyo: The Japanese Respiratory Society Medical Review Co Ltd, 2009.
4. Estrategia del Sistema Nacional de Salud en EPOC. Ministerio de Salud y Política Social, Madrid, 2009.
5. Boletin Oficial del Estado. Ley 42/2010, de 30 de diciembre, por la que se modifica la Ley 28/2005, de 26 de diciembre, de medidas sanitarias frente al tabaquismo y reguladora de la venta, el suministro, el consumo y la publicidad de los productos del tabaco.
6. Soler-Cataluña JJ, Calle M, Cosio BG, Marín JM, Monso E, Alfageme I. Helathcare quality standards in chronic obstructive pulmonary disease. Arch Bronconeumol 2009;45:361-2. http://dx.doi.org/10.1016/j.arbres.2009.05.001
7. Grupo de Trabajo de GesEPOC. Guía de Práctica Clínica para el diagnóstico y tratamiento de pacientes con enfermedad pulmonar obstructiva crónica (EPOC)-Guía Española de la EPOC (GesEPOC). Arch Bronconeumol 2012;48(Supl 1):2-58.
8. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604. http://dx.doi.org/10.1164/rccm.200912-1843CC
9. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003;124:474-81. http://dx.doi.org/10.1378/chest.124.2.474
10. Rennard SI, Vestbo J. The many "small COPDs": COPD should be an orphan disease. Chest 2008;134(3):623-7. http://dx.doi.org/10.1378/chest.07-3059
11. Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD. Identification, definition and implications for guidelines. Arch Bronconeumol 2012;48:86-98. http://dx.doi.org/10.1016/j.arbr.2012.01.003
12. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish COPD guidelines (GesEPOC). Pharmacological treatment of stable COPD. Arch Bronconeumol 2012;48:247-57. http://dx.doi.org/10.1016/j.arbr.2012.05.003
13. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38. http://dx.doi.org/10.1056/NEJMoa0909883
14. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-35. http://dx.doi.org/10.1136/thx.2008.108027
15. Piras B, Miravitlles M. The overlap phenotype: the (missing) link between asthma and COPD. Multidiscip Respir Med 2012;7:8. http://dx.doi.org/10.1186/2049-6958-7-8
16. Miravitlles M. The overlap síndrome between asthma and COPD: implications for management. Hot Topics Respir Med 2011;16:15-20.
17. De Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175:32-9. http://dx.doi.org/10.1164/rccm.200603-381OC
18. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126:59-65. http://dx.doi.org/10.1378/chest.126.1.59
19. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12:127. http://dx.doi.org/10.1186/1465-9921-12-127
20. Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012;48:331-7. http://dx.doi.org/10.1016/j.arbr.2012.06.017
21. Quint JK, Donaldson GC, Hurst JR, Goldring JJP, Seemungal TR, Wedzicha JA. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J 2011;37:501-7. http://dx.doi.org/10.1183/09031936.00035909
22. Kim V, Han MK, Vance GB, et al. The chronic bronchitic phenotype of COPD. An analysis of the COPDGene study. Chest 2011;140:626-33. http://dx.doi.org/10.1378/chest.10-2948
23. Miravitlles M. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med 2011;105:1118-28. http://dx.doi.org/10.1016/j.rmed.2011.02.003
24. Albert RK, Connett J, Biley WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-98. http://dx.doi.org/10.1056/NEJMoa1104623
25. Poole PJ, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; (3):CD001287.
26. Celli BR, Cote CG, Marín JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12. http://dx.doi.org/10.1056/NEJMoa021322
27. Marin JM, Alfageme I, Almagro P, et al. Multicomponent indices to predict survival in COPD: the COllaborative COhorts to assess Multicomponent Indices of COPD in Spain-COCOMICS study. Eur Respir J 2012 Dec 6 [Epub ahead of print]. http://dx.doi.org/10.1183/09031936.00121012
28. Soler-Cataluña JJ, Martínez-García MA, Sánchez LS, Tordera MP, Sánchez PR. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 2009;103:692-9. http://dx.doi.org/10.1016/j.rmed.2008.12.005
29. Esteban C, Quintana JM, Aburto M, et al. Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010;36:292-300. http://dx.doi.org/10.1183/09031936.00021409
30. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011;38:29-35. http://dx.doi.org/10.1183/09031936.00177210
31. Miravitlles M, Soler-Cataluña JJ, Calle M, Soriano J. Treatment of COPD by clinical phenotypes. Putting old evidence into clinical practice. Eur Respir J 2012 Oct 11 [Epub ahead of print]. http://dx.doi.org/10.1183/09031936.00118912